Researchers at the USDA Western Human Nutrition Research Center and clinicians at UC Davis Medical Center are currently conducting a study on the effects of vitamin D supplementation during pregnancy on maternal health and immune function. The investigators believe that vitamin D supplementation at levels greater than the current recommendation is beneficial for maternal health during pregnancy. In particular, there is evidence that vitamin D deficiency during pregnancy puts women at greater risk for diseases like pre-eclampsia, which may be due to an imbalance in immune function at the placenta. This randomized, double-blind study is designed to test this hypothesis. Pregnant women who participate in the study receive either 400 IU or 2,000 IU of vitamin D per day for the duration of their pregnancy. The investigators will collect blood at three time points during pregnancy (16-20 weeks, 26-28 weeks, 36 weeks gestation) for analysis of immune function and vitamin D status. The investigators are also collecting data on clinical parameters, such as blood pressure and glucose tolerance.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
60
Women in this study arm receive 400 IU of vitamin D3 per day, or what is in a standard prenatal multivitamin. They also receive a placebo study supplement.
Women in this arm receive 2,000 IU vitamin D per day: 400 IU from a standard prenatal multivitamin plus an additional 1,600 IU vitamin D3 in the study supplement.
USDA-Western Human Nutrition Research Center
Davis, California, United States
UC Davis Medical Center Obstetrics & Gynecology
Sacramento, California, United States
Change in T-cell cytokine expression
Inflammatory and regulatory cytokines will be measured in cultured T-cells by flow cytometry.
Time frame: 16-20 wks, 26-28 wks, and 36 wks gestation
Change in Vitamin D status
Serum 25-OH vitamin D and 1, 25 (OH)2 Vitamin D
Time frame: 16-20 wks, 26-28 wks, 36 wks gestation
Change in innate immune function
Monocyte and NK cell cytokine expression and response to stimulation with Toll-like Receptor agonists.
Time frame: 16-20 wks, 26-28 wks, 36 wks gestation
Change in blood pressure
Blood pressure will be measured using standard techniques.
Time frame: 16-20 wks, 26-28 wks, 36 wks gestation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.